4DMEDICAL Ltd
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function im… Read more
4DMEDICAL Ltd (4DX) - Net Assets
Latest net assets as of December 2025: AU$-28.40 Million AUD
Based on the latest financial reports, 4DMEDICAL Ltd (4DX) has net assets worth AU$-28.40 Million AUD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$139.55 Million) and total liabilities (AU$167.95 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-28.40 Million |
| % of Total Assets | -20.35% |
| Annual Growth Rate | 57.85% |
| 5-Year Change | -10.11% |
| 10-Year Change | -22.94% |
| Growth Volatility | 102.43 |
4DMEDICAL Ltd - Net Assets Trend (2014–2025)
This chart illustrates how 4DMEDICAL Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for 4DMEDICAL Ltd (2014–2025)
The table below shows the annual net assets of 4DMEDICAL Ltd from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$64.24 Million | 0.00% |
| 2024-12-31 | AU$64.24 Million | -9.43% |
| 2024-06-30 | AU$70.93 Million | 0.00% |
| 2023-12-31 | AU$70.93 Million | -0.75% |
| 2023-06-30 | AU$71.46 Million | 0.00% |
| 2022-12-31 | AU$71.46 Million | +20.08% |
| 2022-06-30 | AU$59.51 Million | 0.00% |
| 2021-12-31 | AU$59.51 Million | -28.61% |
| 2021-06-30 | AU$83.36 Million | 0.00% |
| 2020-12-31 | AU$83.36 Million | +805.82% |
| 2020-06-30 | AU$-11.81 Million | 0.00% |
| 2019-12-31 | AU$-11.81 Million | -359.23% |
| 2019-06-30 | AU$4.56 Million | 0.00% |
| 2018-12-31 | AU$4.56 Million | +20.58% |
| 2018-06-30 | AU$3.78 Million | 0.00% |
| 2017-12-31 | AU$3.78 Million | +16.27% |
| 2017-06-30 | AU$3.25 Million | 0.00% |
| 2016-12-31 | AU$3.25 Million | +250.68% |
| 2016-06-30 | AU$926.64K | 0.00% |
| 2015-12-31 | AU$926.64K | +73.88% |
| 2015-06-30 | AU$532.93K | 0.00% |
| 2014-12-31 | AU$532.93K | -- |
Equity Component Analysis
This analysis shows how different components contribute to 4DMEDICAL Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 18115093000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$239.97 Million | 373.58% |
| Other Comprehensive Income | AU$6.37 Million | 9.92% |
| Total Equity | AU$64.24 Million | 100.00% |
4DMEDICAL Ltd Competitors by Market Cap
The table below lists competitors of 4DMEDICAL Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Baoding Lucky Innovative Materials Co Ltd
SHE:300446
|
$1.03 Billion |
|
Anhui Xinlong Electrical Co Ltd
SHE:002298
|
$1.03 Billion |
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
$1.03 Billion |
|
Aurora Optoelectronics Co Ltd
SHG:600666
|
$1.03 Billion |
|
NOF Corporation
MU:NOF
|
$1.03 Billion |
|
Pennant Group Inc
NASDAQ:PNTG
|
$1.03 Billion |
|
Poya International Co Ltd
TWO:5904
|
$1.03 Billion |
|
SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
NASDAQ:HDL
|
$1.03 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in 4DMEDICAL Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 64,235,164 to 64,235,164, a change of 0 (0.0%).
- Net loss of 30,069,854 reduced equity.
- Share repurchases of 1,360,787 reduced equity.
- New share issuances of 14,703,355 increased equity.
- Other factors increased equity by 16,727,286.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-30.07 Million | -46.81% |
| Share Repurchases | AU$1.36 Million | -2.12% |
| Share Issuances | AU$14.70 Million | +22.89% |
| Other Changes | AU$16.73 Million | +26.04% |
| Total Change | AU$- | 0.00% |
Book Value vs Market Value Analysis
This analysis compares 4DMEDICAL Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 12.67x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.11x to 12.67x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | AU$35.79 | AU$3.79 | x |
| 2015-06-30 | AU$35.79 | AU$3.79 | x |
| 2015-12-31 | AU$37.70 | AU$3.79 | x |
| 2016-06-30 | AU$37.70 | AU$3.79 | x |
| 2016-12-31 | AU$0.02 | AU$3.79 | x |
| 2017-06-30 | AU$0.02 | AU$3.79 | x |
| 2017-12-31 | AU$0.02 | AU$3.79 | x |
| 2018-06-30 | AU$0.02 | AU$3.79 | x |
| 2018-12-31 | AU$0.03 | AU$3.79 | x |
| 2019-06-30 | AU$0.03 | AU$3.79 | x |
| 2019-12-31 | AU$-0.04 | AU$3.79 | x |
| 2020-06-30 | AU$-0.04 | AU$3.79 | x |
| 2020-12-31 | AU$0.32 | AU$3.79 | x |
| 2021-06-30 | AU$0.32 | AU$3.79 | x |
| 2021-12-31 | AU$0.20 | AU$3.79 | x |
| 2022-06-30 | AU$0.20 | AU$3.79 | x |
| 2022-12-31 | AU$0.24 | AU$3.79 | x |
| 2023-06-30 | AU$0.24 | AU$3.79 | x |
| 2023-12-31 | AU$0.22 | AU$3.79 | x |
| 2024-06-30 | AU$0.22 | AU$3.79 | x |
| 2024-12-31 | AU$0.30 | AU$3.79 | x |
| 2025-06-30 | AU$0.30 | AU$3.79 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently 4DMEDICAL Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -46.81%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -513.72%
- • Asset Turnover: 0.06x
- • Equity Multiplier: 1.48x
- Recent ROE (-46.81%) is above the historical average (-62.78%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -26.09% | -54.99% | 0.37x | 1.27x | AU$-192.32K |
| 2015 | -26.09% | -54.99% | 0.37x | 1.27x | AU$-192.32K |
| 2015 | -86.94% | -226.93% | 0.32x | 1.19x | AU$-887.86K |
| 2016 | -86.94% | -226.93% | 0.32x | 1.19x | AU$-887.86K |
| 2016 | -122.29% | -206438.29% | 0.00x | 1.52x | AU$-4.30 Million |
| 2017 | -122.29% | -206438.29% | 0.00x | 1.52x | AU$-4.30 Million |
| 2017 | -104.20% | -498.82% | 0.14x | 1.44x | AU$-4.31 Million |
| 2018 | -104.20% | -498.82% | 0.14x | 1.44x | AU$-4.31 Million |
| 2018 | -142.48% | -933.96% | 0.08x | 1.98x | AU$-6.95 Million |
| 2019 | -142.48% | -933.96% | 0.08x | 1.98x | AU$-6.95 Million |
| 2019 | 0.00% | -1782.99% | 0.08x | 0.00x | AU$-20.79 Million |
| 2020 | 0.00% | -1782.99% | 0.08x | 0.00x | AU$-20.79 Million |
| 2020 | -25.70% | -9872.21% | 0.00x | 1.11x | AU$-29.76 Million |
| 2021 | -25.70% | -9872.21% | 0.00x | 1.11x | AU$-29.76 Million |
| 2021 | -41.32% | -2332.63% | 0.01x | 1.25x | AU$-30.54 Million |
| 2022 | -41.32% | -2332.63% | 0.01x | 1.25x | AU$-30.54 Million |
| 2022 | -44.02% | -4378.04% | 0.01x | 1.30x | AU$-38.61 Million |
| 2023 | -44.02% | -4378.04% | 0.01x | 1.30x | AU$-38.61 Million |
| 2023 | -50.73% | -958.34% | 0.03x | 1.69x | AU$-43.07 Million |
| 2024 | -50.73% | -958.34% | 0.03x | 1.69x | AU$-43.07 Million |
| 2024 | -46.81% | -513.72% | 0.06x | 1.48x | AU$-36.49 Million |
| 2025 | -46.81% | -513.72% | 0.06x | 1.48x | AU$-36.49 Million |
Industry Comparison
This section compares 4DMEDICAL Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $16,286,911
- Average return on equity (ROE) among peers: -340.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| 4DMEDICAL Ltd (4DX) | AU$-28.40 Million | -26.09% | N/A | $1.03 Billion |
| Adherium Ltd (ADR) | $34.53 Million | -3.63% | 0.08x | $2.37 Million |
| Aroa Biosurgery Ltd (ARX) | $-22.65 Million | 0.00% | 0.00x | $92.74 Million |
| Atomo Diagnostics Ltd (AT1) | $34.48 Million | -26.73% | 0.05x | $8.96 Million |
| Control Bionics Ltd (CBL) | $6.09 Million | -15.97% | 0.04x | $4.98 Million |
| Cardiex Ltd (CDX) | $3.03 Million | -101.61% | 0.73x | $4.25 Million |
| Compumedics Ltd (CMP) | $9.21 Million | -30.70% | 1.16x | $13.08 Million |
| Cochlear Ltd (COH) | $75.42 Million | 53.19% | 1.13x | $7.01 Billion |
| Cleo Diagnostics Ltd (COV) | $5.83 Million | -68.54% | 0.19x | $23.47 Million |
| Conneqt Health Limited (CQT) | $633.50K | -2871.98% | 13.72x | $4.66 Million |